{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:27:03Z","timestamp":1791584823819,"version":"4.3.4"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tice.2026.103524","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:56:55Z","timestamp":1775782615000},"page":"103524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Blood-brain barrier modulation for targeted central nervous system drug delivery in neurodegenerative and demyelinating disorders"],"prefix":"10.1016","volume":"101","author":[{"given":"Daniel Ejim","family":"Uti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Ugo","family":"Alum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Mathias","family":"Okpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine E.","family":"Egbung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenavine Onyinye","family":"Mbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103524_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuroscience.2025.06.037","article-title":"Role of Blood-Brain barrier in bacterial translocation","volume":"580","author":"Aborode","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.tice.2026.103524_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2019.12.047","article-title":"Current challenges and emerging opportunities of CAR-T cell therapies","volume":"319","author":"Abreu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tice.2026.103524_bib3","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3390\/biomedicines9121834","article-title":"Drug delivery challenges in brain disorders across the blood\u2013brain barrier: novel methods and future considerations for improved therapy","volume":"9","author":"Achar","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.tice.2026.103524_bib4","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3390\/biomedicines9121834","article-title":"Drug delivery challenges in brain disorders across the blood\u2013brain barrier: novel methods and future considerations for improved therapy","volume":"9","author":"Achar","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.tice.2026.103524_bib5","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s11095-023-03593-y","article-title":"TIMP-1 protects tight junctions of brain endothelial cells From MMP-mediated degradation","volume":"40","author":"Ahmadighadykolaei","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tice.2026.103524_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3390\/genes16080850","article-title":"CRISPR in neurodegenerative diseases treatment: an alternative approach to current therapies","volume":"16","author":"Akbar","year":"2025","journal-title":"Genes"},{"key":"10.1016\/j.tice.2026.103524_bib7","first-page":"106","article-title":"Ligands for oral delivery of peptides across the blood-brain-barrier","volume":"1","author":"Al Gailani","year":"2022","journal-title":"Acta Mater. Med."},{"key":"10.1016\/j.tice.2026.103524_bib8","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.3390\/ijms22073742","article-title":"Disease-induced modulation of drug transporters at the blood\u2013brain barrier level","volume":"22","author":"Al Rihani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6564585","article-title":"Blood-brain barrier overview: structural and functional correlation","volume":"2021","author":"Alahmari","year":"2021","journal-title":"Neural Plast."},{"key":"10.1016\/j.tice.2026.103524_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6564585","article-title":"Blood-brain barrier overview: structural and functional correlation","volume":"2021","author":"Alahmari","year":"2021","journal-title":"Neural Plast."},{"key":"10.1016\/j.tice.2026.103524_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13041-022-00937-4","article-title":"Blood\u2013brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders","volume":"15","author":"Alajangi","year":"2022","journal-title":"Mol. Brain"},{"key":"10.1016\/j.tice.2026.103524_bib12","doi-asserted-by":"crossref","first-page":"16288","DOI":"10.3390\/ijms242216288","article-title":"Blood\u2013brain barrier breakdown in Alzheimer\u2019s disease: mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13024-023-00675-8","article-title":"Peptide-based approaches to directly target alpha-synuclein in Parkinson\u2019s disease","volume":"18","author":"Allen","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tice.2026.103524_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1101379","article-title":"The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis","volume":"17","author":"Angelini","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tice.2026.103524_bib15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/pharmaceutics13111779","article-title":"Blood-brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview","volume":"13","author":"Archie","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib16","first-page":"353","article-title":"Mechanism and applications of CRISPR\/Cas-9-mediated genome editing","volume":"15","author":"Asmamaw","year":"2021","journal-title":"Biologics"},{"key":"10.1016\/j.tice.2026.103524_bib17","doi-asserted-by":"crossref","unstructured":"Awasthi, R., Maier, H.J., Zhang, J., Lim, S.: Kymriah\u00ae (tisagenlecleucel) \u2013 An overview of the clinical development journey of the first approved CAR-T therapy. Hum Vaccin Immunother. 19, 2210046. https:\/\/doi.org\/10.1080\/21645515.2023.2210046.","DOI":"10.1080\/21645515.2023.2210046"},{"key":"10.1016\/j.tice.2026.103524_bib18","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1038\/s41467-023-38703-2","article-title":"Antigen recognition detains CD8+ T cells at the blood-brain barrier and contributes to its breakdown","volume":"14","author":"Aydin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2026.103524_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.56397\/CRMS.2023.09.03","article-title":"Hydrophobicity, transport and target sites of action are important for the activity of many drugs","volume":"2","author":"Ayyad","year":"2023","journal-title":"CRMS"},{"key":"10.1016\/j.tice.2026.103524_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113595","article-title":"Mechanisms of receptor-mediated transcytosis at the blood-brain barrier","volume":"381","author":"Baghirov","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tice.2026.103524_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1347877","article-title":"Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features","volume":"15","author":"Ballest\u00edn","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103524_bib22","article-title":"The impact of ATP-binding cassette transporters in the diseased brain: Context matters","volume":"5","author":"Baltira","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.tice.2026.103524_bib23","doi-asserted-by":"crossref","first-page":"23202","DOI":"10.1039\/D5NR02548F","article-title":"Crossing the blood\u2013brain barrier: advances in dendrimer-based nanocarriers for central nervous system delivery","volume":"17","author":"Bharadwaj","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.tice.2026.103524_bib24","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3389\/fphys.2018.01942","article-title":"Tight junction proteins and signaling pathways in cancer and inflammation: a functional crosstalk","volume":"9","author":"Bhat","year":"2019","journal-title":"Front Physiol."},{"key":"10.1016\/j.tice.2026.103524_bib25","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.3390\/pharmaceutics15122658","article-title":"Drug delivery to the brain: recent advances and unmet challenges","volume":"15","author":"Bhunia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jlcr.4023","article-title":"Peptides for trans-blood\u2013brain barrier delivery","volume":"66","author":"Blades","year":"2023","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.tice.2026.103524_bib27","doi-asserted-by":"crossref","first-page":"12699","DOI":"10.3390\/ijms241612699","article-title":"Blood\u2013brain barrier breakdown in neuroinflammation: current in vitro models","volume":"24","author":"Brandl","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-bioeng-110220-023800","article-title":"Recent advancements in electroporation technologies: from bench to clinic","volume":"25","author":"Campelo","year":"2023","journal-title":"Annu Rev. Biomed. Eng."},{"key":"10.1016\/j.tice.2026.103524_bib29","doi-asserted-by":"crossref","first-page":"14667","DOI":"10.3390\/ijms232314667","article-title":"Regulation of P-Glycoprotein in the Brain","volume":"23","author":"Chai","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.tice.2026.103524_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/jox13030026","article-title":"Cytochrome P450 gene families: role in plant secondary metabolites production and plant defense","volume":"13","author":"Chakraborty","year":"2023","journal-title":"JoX"},{"key":"10.1016\/j.tice.2026.103524_bib31","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.3390\/ijms24043383","article-title":"Human Cytochrome P450 1, 2, 3 families as pharmacogenes with emphases on their antimalarial and antituberculosis drugs and prevalent African alleles","volume":"24","author":"Chamboko","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.tice.2026.103524_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166967","article-title":"Blood-brain barrier transporters: an overview of function, dysfunction in Alzheimer\u2019s disease and strategies for treatment","volume":"1870","author":"Chaves","year":"2024","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.tice.2026.103524_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-023-01925-5","article-title":"Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy","volume":"23","author":"Chehelgerdi","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2026.103524_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70345","article-title":"Immediate Motor Control Enhancement via Pallidothalamic Tract (PTT) circuit ablation: a dual-target MR-guided focused ultrasound approach for tremor-dominant Parkinson\u2019s disease","volume":"32","author":"Chen","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tice.2026.103524_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","article-title":"Cellular and molecular mechanisms of the blood\u2013brain barrier dysfunction in neurodegenerative diseases","volume":"21","author":"Chen","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.tice.2026.103524_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-brain barrier dysfunction and Alzheimer\u2019s disease: associations, pathogenic mechanisms, and therapeutic potential","volume":"15","author":"Chen","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tice.2026.103524_bib37","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/pharmaceutics13071084","article-title":"Focused ultrasound combined with microbubbles in central nervous system applications","volume":"13","author":"Chen","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib38","series-title":"TICToK: a comprehensive knowledgebase of tattoo ink chemicals and investigation of their associated toxicities and regulations","author":"Chivukula","year":"2025"},{"key":"10.1016\/j.tice.2026.103524_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s10876-024-02691-0","article-title":"Advancing autonomous nanomedicine: bridging the gap from concept to potential clinical studies","author":"Chohan","year":"2024","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib40","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1021\/acs.chemrev.1c00677","article-title":"Recent advances in microscale electroporation","volume":"122","author":"Choi","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib41","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1080\/17425247.2023.2286371","article-title":"Strategies to identify, engineer, and validate antibodies targeting blood\u2013brain barrier receptor-mediated transcytosis systems for CNS drug delivery","volume":"20","author":"Choi","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.tice.2026.103524_bib42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/cells13060511","article-title":"Recent research trends in neuroinflammatory and neurodegenerative disorders","volume":"13","author":"Cohen","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.tice.2026.103524_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135633","article-title":"\u03b1-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson\u2019s disease","volume":"6","author":"Cole","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.tice.2026.103524_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cells15030232","article-title":"When barriers break: tight junction regulation and dynamic alterations of barrier integrity in neurological injury","volume":"15","author":"Colpitts","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.tice.2026.103524_bib45","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2174\/1568026620666200603121224","article-title":"Developing a multi-target model to predict the activity of monoamine oxidase A and B Drugs","volume":"20","author":"Concu","year":"2020","journal-title":"CTMC"},{"key":"10.1016\/j.tice.2026.103524_bib46","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12951-024-02892-9","article-title":"Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium","volume":"22","author":"Cong","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.tice.2026.103524_bib47","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/ejn.16229","article-title":"Blood\u2013brain barrier disruption in dementia: nano-solutions as new treatment options","volume":"59","author":"Cooper","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tice.2026.103524_bib48","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1021\/acs.jmedchem.2c01824","article-title":"Explaining blood\u2013brain barrier permeability of small molecules by integrated analysis of different transport mechanisms","volume":"66","author":"Cornelissen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tice.2026.103524_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2015.12.041","article-title":"Concepts, technologies, and practices for drug delivery past the blood\u2013brain barrier to the central nervous system","volume":"240","author":"Crawford","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tice.2026.103524_bib50","unstructured":"CRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001\u2122 in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) Congress | Vertex Pharmaceuticals, \u3008https:\/\/investors.vrtx.com\/news-releases\/news-release-details\/crispr-therapeutics-and-vertex-announce-new-clinical-data\u3009."},{"key":"10.1016\/j.tice.2026.103524_bib51","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/md21070406","article-title":"The rare marine bioactive compounds in neurological disorders and diseases: is the blood-brain barrier an obstacle or a target?","volume":"21","author":"Diao","year":"2023","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.tice.2026.103524_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-neuro-091922-031205","article-title":"Astrocyte endfeet in brain function and pathology: open questions","volume":"46","author":"D\u00edaz-Castro","year":"2023","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.tice.2026.103524_bib53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/17460441.2023.2294118","article-title":"Designing drugs optimized for both blood\u2013brain barrier permeation and intra-cerebral partition","volume":"19","author":"Dichiara","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.tice.2026.103524_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.mattod.2020.02.001","article-title":"Overcoming blood-brain barrier transport: advances in nanoparticle-based drug delivery strategies","author":"Ding","year":"2020","journal-title":"Mater. Today"},{"key":"10.1016\/j.tice.2026.103524_bib55","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.3390\/ijms25115601","article-title":"The basic requirement of tight junction proteins in blood-brain barrier function and their role in pathologies","volume":"25","author":"Dithmer","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib56","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.3390\/ijms25115601","article-title":"The basic requirement of tight junction proteins in blood-brain barrier function and their role in pathologies","volume":"25","author":"Dithmer","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib57","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.3390\/ijms25115601","article-title":"The basic requirement of tight junction proteins in blood-brain barrier function and their role in pathologies","volume":"25","author":"Dithmer","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib58","series-title":"Anatomy, Head and Neck: Blood Brain Barrier","article-title":"Treasure Island (FL)","author":"Dotiwala","year":"2024"},{"key":"10.1016\/j.tice.2026.103524_bib59","series-title":"Anatomy, Head and Neck: Blood Brain Barrier","article-title":"Treasure Island (FL)","author":"Dotiwala","year":"2025"},{"key":"10.1016\/j.tice.2026.103524_bib60","doi-asserted-by":"crossref","unstructured":"Edinoff, A.N., Nguyen, L.H., Odisho, A.S., Maxey, B.S., Pruitt, J.W., Girma, B., Cornett, E.M., Kaye, A.M., Kaye, A.D.: The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular Atrophy. Orthop Rev (Pavia). 13, 24934. https:\/\/doi.org\/10.52965\/001c.24934.","DOI":"10.52965\/001c.24934"},{"key":"10.1016\/j.tice.2026.103524_bib61","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/cancers17162700","article-title":"The quest for non-invasive diagnosis: a review of liquid biopsy in glioblastoma","volume":"17","author":"Elias","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.tice.2026.103524_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in drug delivery systems, challenges and future directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.tice.2026.103524_bib63","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3390\/pharmaceutics15102441","article-title":"Strategies for drug delivery into the brain: a review on adenosine receptors modulation for central nervous system diseases therapy","volume":"15","author":"Fernandez","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.747726","article-title":"A multifaceted approach to optimizing AAV delivery to the brain for the treatment of neurodegenerative diseases","volume":"15","author":"Fischell","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tice.2026.103524_bib65","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/mds.27805","article-title":"Focused ultrasound in Parkinson\u2019s disease: A twofold path toward disease modification","volume":"34","author":"Foffani","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tice.2026.103524_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood-2020-139575","article-title":"Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent \u03b2-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells","volume":"136","author":"Frangoul","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tice.2026.103524_bib67","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/pharmaceutics17081074","article-title":"Anti-PEG antibodies and their biological impact on PEGylated drugs: challenges and strategies for optimization","volume":"17","author":"Fu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40262-018-0659-0","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling in pediatric drug development, and the importance of standardized scaling of clearance","volume":"58","author":"Germovsek","year":"2019","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.tice.2026.103524_bib70","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3390\/pharmaceutics15071999","article-title":"Cell-penetrating and targeted peptides delivery systems as potential pharmaceutical carriers for enhanced delivery across the blood\u2013brain barrier (BBB)","volume":"15","author":"Ghorai","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib71","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5698\/1535-7597-14.3.136","article-title":"P-glycoprotein expression and pharmacoresistant epilepsy: cause or consequence?: p-glycoprotein expression and pharmacoresistant epilepsy","volume":"14","author":"Gidal","year":"2014","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.tice.2026.103524_bib72","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/jpet.119.257113","article-title":"Pharmacokinetic and pharmacodynamic properties of drug delivery systems","volume":"370","author":"Glassman","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.tice.2026.103524_bib73","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/jpm13050751","article-title":"CmPn\/CmP signaling networks in the maintenance of the blood vessel barrier","volume":"13","author":"Gnanasekaran","year":"2023","journal-title":"JPM"},{"key":"10.1016\/j.tice.2026.103524_bib74","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12035-025-05592-z","article-title":"The breakdown of neurovascular barriers: molecular mechanisms of tight junction dysfunction","volume":"63","author":"Gopal","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tice.2026.103524_bib75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yao.2023.01.017","article-title":"Advances in blood-brain barrier disruption to facilitate drug delivery for infiltrative gliomas","volume":"3","author":"Gould","year":"2023","journal-title":"Adv. Oncol."},{"key":"10.1016\/j.tice.2026.103524_bib76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","article-title":"Claudin-5: gatekeeper of neurological function","volume":"16","author":"Greene","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.tice.2026.103524_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","article-title":"Claudin-5: gatekeeper of neurological function","volume":"16","author":"Greene","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.tice.2026.103524_bib78","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/genes14020272","article-title":"Effect of the Rho-Kinase\/ROCK signaling pathway on cytoskeleton components","volume":"14","author":"Guan","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.tice.2026.103524_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102070","article-title":"The blood-brain barrier, a key bridge to treat neurodegenerative diseases","volume":"91","author":"Hang","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.679602","article-title":"Hitchhiking on controlled-release drug delivery systems: opportunities and challenges for cancer vaccines","volume":"12","author":"Han","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.tice.2026.103524_bib81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12987-023-00424-5","article-title":"The CLDN5 gene at the blood-brain barrier in health and disease","volume":"20","author":"Hashimoto","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.tice.2026.103524_bib82","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s40263-020-00766-w","article-title":"Overview of current drug delivery methods across the blood\u2013brain barrier for the treatment of primary brain tumors","volume":"34","author":"Haumann","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tice.2026.103524_bib83","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/pharmaceutics13081286","article-title":"Assessing the functional redundancy between P-gp and BCRP in controlling the brain distribution and biliary excretion of dual substrates with PET imaging in mice","volume":"13","author":"Hern\u00e1ndez-Lozano","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cells7040024","article-title":"Towards Improvements for Penetrating the Blood\u2013Brain Barrier\u2014recent progress from a material and pharmaceutical perspective","volume":"7","author":"He","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.tice.2026.103524_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166992","article-title":"The role of astrocyte in neuroinflammation in traumatic brain injury","volume":"1870","author":"He","year":"2024","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.tice.2026.103524_bib86","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s11095-022-03193-2","article-title":"Pharmacoproteomics of brain barrier transporters and substrate design for the brain targeted drug delivery","volume":"39","author":"Huttunen","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.tice.2026.103524_bib87","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/17425247.2024.2355180","article-title":"Improving drug delivery to the brain: the prodrug approach","volume":"21","author":"Huttunen","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.tice.2026.103524_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/app13106045","article-title":"Impact of cytochrome P450 enzymes on the phase I metabolism of drugs","author":"Iacopetta","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1368018","article-title":"A novel histone deacetylase inhibitor W2A-16 improves the barrier integrity in brain vascular endothelial cells","volume":"18","author":"Inoue","year":"2024","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.tice.2026.103524_bib90","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2174\/1871520616666151120121928","article-title":"Blood-brain barrier and breast cancer resistance protein: a limit to the therapy of CNS tumors and neurodegenerative diseases","volume":"16","author":"Iorio","year":"2016","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.tice.2026.103524_bib91","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s40001-024-01915-3","article-title":"Alzheimer\u2019s disease and drug delivery across the blood\u2013brain barrier: approaches and challenges","volume":"29","author":"Iqbal","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.tice.2026.103524_bib92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/pharmaceutics17030281","article-title":"Nanotechnology to overcome blood\u2013brain barrier permeability and damage in neurodegenerative diseases","volume":"17","author":"Jim\u00e9nez","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/pharmaceutics17030281","article-title":"Nanotechnology to overcome blood\u2013brain barrier permeability and damage in neurodegenerative diseases","volume":"17","author":"Jim\u00e9nez","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib94","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.tice.2026.103524_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115621","article-title":"Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting","volume":"223","author":"Kampasis","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib96","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12929-023-00981-9","article-title":"Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges","volume":"30","author":"Kang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib97","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","article-title":"AAV vectors applied to the treatment of CNS disorders: clinical status and challenges","volume":"355","author":"Kang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tice.2026.103524_bib98","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1021\/acsbiomaterials.2c01329","article-title":"Exosome-based smart drug delivery tool for cancer theranostics","volume":"9","author":"Kar","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.tice.2026.103524_bib99","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/membranes13030343","article-title":"Potential of lipid-based nanocarriers against two major barriers to drug delivery\u2014skin and blood\u2013brain barrier","volume":"13","author":"Khan","year":"2023","journal-title":"Membranes"},{"key":"10.1016\/j.tice.2026.103524_bib100","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/jcm14020386","article-title":"The crucial role of the blood\u2013brain barrier in neurodegenerative diseases: mechanisms of disruption and therapeutic implications","volume":"14","author":"Kim","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tice.2026.103524_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400280","article-title":"Transformative impact of nanocarrier-mediated drug delivery: overcoming biological barriers and expanding therapeutic horizons","volume":"4","author":"Kim","year":"2024","journal-title":"Small Sci."},{"key":"10.1016\/j.tice.2026.103524_bib102","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tice.2026.103524_bib103","article-title":"Drug delivery strategies to cross the blood-brain barrier in Alzheimer\u2019s disease: a comprehensive review on three promising strategies","volume":"12","author":"de Koning","year":"2025","journal-title":"J. Prev. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.tice.2026.103524_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2026.106658","article-title":"The role of blood-brain barrier integrity in the pathophysiology and progression of psychiatric disorders","volume":"185","author":"Konstantinou","year":"2026","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/futurepharmacol4020020","article-title":"Nanotechnology-driven therapeutic innovations in neurodegenerative disorders: a focus on Alzheimer\u2019s and Parkinson\u2019s Disease","volume":"4","author":"Krsek","year":"2024","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.tice.2026.103524_bib106","doi-asserted-by":"crossref","DOI":"10.5599\/admet.2043","article-title":"Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: a comprehensive review","author":"Kulkarni","year":"2023","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.tice.2026.103524_bib107","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1802155115","article-title":"Contributions of the glycocalyx, endothelium, and extravascular compartment to the blood\u2013brain barrier","volume":"115","author":"Kutuzov","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.tice.2026.103524_bib109","first-page":"a041422","article-title":"The blood-brain barrier: composition, properties, and roles in brain health","author":"Lacoste","year":"2024","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tice.2026.103524_bib110","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1177\/0271678X19867980","article-title":"Modeling hyperosmotic blood\u2013brain barrier opening within human tissue-engineered in vitro brain microvessels","volume":"40","author":"Linville","year":"2020","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.tice.2026.103524_bib111","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/03602532.2023.2180028","article-title":"Relationship between blood\u2013brain barrier changes and drug metabolism under high-altitude hypoxia: obstacle or opportunity for drug transport?","volume":"55","author":"Liu","year":"2023","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib112","first-page":"1748","article-title":"Dysregulation of ion channels and transporters and blood-brain barrier dysfunction in Alzheimer\u2019s disease and vascular dementia","volume":"15","author":"Liu","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.tice.2026.103524_bib113","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12951-025-03415-w","article-title":"Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood\u2013brain barrier permeability","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.tice.2026.103524_bib114","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12951-025-03415-w","article-title":"Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood\u2013brain barrier permeability","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.tice.2026.103524_bib115","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.14336\/AD.2021.0510","article-title":"The applications of focused ultrasound (FUS) in Alzheimer\u2019s disease treatment: a systematic review on both animal and human studies","volume":"12","author":"Liu","year":"2021","journal-title":"Aging Dis."},{"key":"10.1016\/j.tice.2026.103524_bib116","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1016\/j.apsb.2025.10.026","article-title":"Progress in peptide and protein therapeutics: Challenges and strategies","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tice.2026.103524_bib117","doi-asserted-by":"crossref","first-page":"51","DOI":"10.26599\/AUDT.2026.250050","article-title":"Focused ultrasound combined with microbubbles for inducing blood-brain barrier opening: cavitation monitoring and control","volume":"10","author":"Li","year":"2026","journal-title":"Adv. Ultrasound Diagn. Ther."},{"key":"10.1016\/j.tice.2026.103524_bib118","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/pharmaceutics17010109","article-title":"Targeting brain drug delivery with macromolecules through receptor-mediated transcytosis","volume":"17","author":"Li","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib119","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.apsb.2019.10.001","article-title":"Current trends in drug metabolism and pharmacokinetics","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tice.2026.103524_bib120","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3389\/fphys.2020.00914","article-title":"Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders","volume":"11","author":"Lochhead","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tice.2026.103524_bib121","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2174\/0118715273269881231012062255","article-title":"The essential role of astrocytes in neurodegeneration and neuroprotection","volume":"23","author":"L\u00f3pez Couselo","year":"2024","journal-title":"CNSNDDT"},{"key":"10.1016\/j.tice.2026.103524_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.863677","article-title":"New Insight in HDACs: potential therapeutic targets for the treatment of atherosclerosis","volume":"13","author":"Luan","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.tice.2026.103524_bib123","article-title":"Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system","volume":"31","author":"Luo","year":"2025","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.tice.2026.103524_bib124","article-title":"Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system","volume":"31","author":"Luo","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.tice.2026.103524_bib125","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/cells8020184","article-title":"Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release","volume":"8","author":"Mahmoud","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.tice.2026.103524_bib126","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s13311-022-01228-5","article-title":"Current chemical, biological, and physiological views in the development of successful brain-targeted pharmaceutics","volume":"19","author":"Markowicz-Piasecka","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tice.2026.103524_bib127","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/02611929231157756","article-title":"Poor Translatability of biomedical research using animals \u2014 a narrative review","volume":"51","author":"Marshall","year":"2023","journal-title":"Alter. Lab Anim."},{"key":"10.1016\/j.tice.2026.103524_bib128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1573408012666160402001715","article-title":"Monoamine oxidase inhibitors: perspective design for the treatment of depression and neurological disorders","volume":"12","author":"Mathew","year":"2016","journal-title":"CEI"},{"key":"10.1016\/j.tice.2026.103524_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultras.2025.107734","article-title":"Ultrasound-induced blood-brain barrier opening and selenium-nanoparticle injection lower seizure activity: a mouse model of temporal lobe epilepsy","volume":"155","author":"Mathon","year":"2025","journal-title":"Ultrasonics"},{"key":"10.1016\/j.tice.2026.103524_bib130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/cells11010133","article-title":"The blood\u2013brain barrier, an evolving concept based on technological advances and cell\u2013cell communications","volume":"11","author":"Menaceur","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tice.2026.103524_bib131","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-04015-9","article-title":"Receptor-assisted nanotherapeutics for overcoming the blood\u2013brain barrier","author":"Mhaske","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tice.2026.103524_bib132","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.2147\/IJN.S323831","article-title":"Current trends and challenges in pharmacoeconomic aspects of nanocarriers as drug delivery systems for cancer treatment","volume":"16","author":"Milewska","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.tice.2026.103524_bib133","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tice.2026.103524_bib134","doi-asserted-by":"crossref","unstructured":"Morofuji, Y., Nakagawa, S.: Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning. Current Pharmaceutical Design. 26, 1466\u20131485. https:\/\/doi.org\/10.2174\/1381612826666200224112534.","DOI":"10.2174\/1381612826666200224112534"},{"key":"10.1016\/j.tice.2026.103524_bib135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jconrel.2023.10.052","article-title":"Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis","volume":"364","author":"Mwema","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tice.2026.103524_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116128","article-title":"Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology","volume":"223","author":"Nagaoka","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tice.2026.103524_bib137","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.tice.2026.103524_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2022.8405","article-title":"A guide through conventional and modern cancer treatment modalities: a specific focus on glioblastoma cancer therapy (Review)","volume":"48","author":"Naser","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tice.2026.103524_bib139","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bcp.2012.01.002","article-title":"Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance","volume":"83","author":"Natarajan","year":"2012","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.tice.2026.103524_bib140","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.3390\/pharmaceutics15112599","article-title":"Non-Invasive Drug Delivery across the Blood\u2013Brain barrier: a prospective analysis","volume":"15","author":"Niazi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105844","article-title":"Discovery and validation of biomarkers for Parkinson\u2019s disease from human cerebrospinal fluid using mass spectrometry-based proteomics analysis","volume":"118","author":"Oh","year":"2025","journal-title":"eBioMedicine"},{"key":"10.1016\/j.tice.2026.103524_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1207007","article-title":"Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration","volume":"16","author":"Packer","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tice.2026.103524_bib143","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3390\/pharmaceutics15102473","article-title":"Uptake transporters at the blood\u2013brain barrier and their role in brain drug disposition","volume":"15","author":"Parvez","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib144","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/BST20220830","article-title":"The role of the blood\u2013brain barrier during neurological disease and infection","volume":"51","author":"Patabendige","year":"2023","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.tice.2026.103524_bib145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/BST20220830","article-title":"The role of the blood\u2013brain barrier during neurological disease and infection","volume":"51","author":"Patabendige","year":"2023","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.tice.2026.103524_bib146","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/pharmaceutics14122719","article-title":"Current update on transcellular brain drug delivery","volume":"14","author":"Pawar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib147","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(24)00476-9","article-title":"Crossing the blood\u2013brain barrier: emerging therapeutic strategies for neurological disease","volume":"24","author":"Pedder","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tice.2026.103524_bib148","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s42494-024-00171-6","article-title":"Advancements in the application of nanotechnology for the management of epileptic seizures","volume":"6","author":"Ping","year":"2024","journal-title":"Acta Epileptol."},{"key":"10.1016\/j.tice.2026.103524_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115637","article-title":"A new era in brain drug delivery: integrating multivalency and computational optimisation for blood\u2013brain barrier permeation","volume":"224","author":"Porro","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115637","article-title":"A new era in brain drug delivery: Integrating multivalency and computational optimisation for blood\u2013brain barrier permeation","volume":"224","author":"Porro","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib151","article-title":"Research progress of blood-brain barrier penetrating and brain diseases therapy by natural biopolymer - based nanomedicine delivery systems","volume":"37","author":"Qin","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.tice.2026.103524_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1353003","article-title":"Advancements in strategies for overcoming the blood\u2013brain barrier to deliver brain-targeted drugs","volume":"16","author":"Qu","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tice.2026.103524_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121949","article-title":"Exosomes based strategies for brain drug delivery","volume":"293","author":"Rehman","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.tice.2026.103524_bib154","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.791709","article-title":"The Bradykinin B2 Receptor Agonist (NG291) causes rapid onset of transient blood\u2013brain barrier disruption without evidence of Early Brain Injury","volume":"15","author":"Rodr\u00edguez-Mass\u00f3","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tice.2026.103524_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639369","article-title":"Common Peripheral immunity mechanisms in multiple sclerosis and Alzheimer\u2019s Disease","volume":"12","author":"Rossi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103524_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37533","article-title":"A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer\u2019s disease","volume":"10","author":"Rouhi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.tice.2026.103524_bib157","first-page":"1","article-title":"Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier","author":"Russell","year":"2024","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib158","article-title":"siRNA drug delivery across the blood-brain barrier in Alzheimer\u2019s Disease","volume":"199","author":"Sajid","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib159","doi-asserted-by":"crossref","DOI":"10.2174\/1381612829666230707121415","article-title":"Recent update on pharmacokinetics and drug metabolism in CNS-based drug discovery","author":"Sanap","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tice.2026.103524_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122759","article-title":"Access to the CNS: Strategies to overcome the BBB","volume":"636","author":"S\u00e1nchez-Dengra","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tice.2026.103524_bib161","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.3390\/ijms23158418","article-title":"Targeting fibronectin to overcome remyelination failure in multiple sclerosis: the need for brain- and lesion-targeted drug delivery","volume":"23","author":"van Schaik","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib162","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/cells13020150","article-title":"Involvement of astrocytes in the formation, maintenance, and function of the blood\u2013brain barrier","volume":"13","author":"Schiera","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.tice.2026.103524_bib163","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/biomedicines13092167","article-title":"Intrathecal therapies for neurodegenerative diseases: a review of current approaches and the urgent need for advanced delivery systems","volume":"13","author":"Schreiner","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.tice.2026.103524_bib164","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/pharmrev.120.000025","article-title":"ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery","volume":"75","author":"Schulz","year":"2023","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.tice.2026.103524_bib165","doi-asserted-by":"crossref","first-page":"25910","DOI":"10.1039\/D5RA03578C","article-title":"Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery","volume":"15","author":"Senanayake","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.tice.2026.103524_bib166","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.3390\/ijms26178703","article-title":"Knocking on Cells\u2019 door: strategic approaches for miRNA and siRNA in Anticancer Therapy","volume":"26","author":"Serra","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib167","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.3390\/ijms21239188","article-title":"Glia in neurodegeneration: the housekeeper, the defender and the perpetrator","volume":"21","author":"Sheeler","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.tice.2026.103524_bib168","article-title":"Breaking through the blood-brain barrier for different kinds of drugs: challenges, solutions, and perspectives","volume":"2","author":"She","year":"2024","journal-title":"BME Horiz."},{"key":"10.1016\/j.tice.2026.103524_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2024.1469250","article-title":"Therapeutic ultrasound: an innovative approach for targeting neurological disorders affecting the basal ganglia","volume":"18","author":"Singh","year":"2024","journal-title":"Front Neuroanat."},{"key":"10.1016\/j.tice.2026.103524_bib170","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2174\/1570159X20999220131163504","article-title":"Transient opening of the blood-brain barrier by vasoactive peptides to increase CNS drug delivery: reality versus wishful thinking?","volume":"20","author":"Smith-Cohn","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.tice.2026.103524_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.103008","article-title":"Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: an overview","volume":"320","author":"Song","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.tice.2026.103524_bib172","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.omtm.2022.09.002","article-title":"Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model","volume":"27","author":"Song","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tice.2026.103524_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115450","article-title":"Translational strategies and systems biology insights for blood-brain barrier opening and delivery in brain tumors and Alzheimer\u2019s disease","volume":"167","author":"Song","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tice.2026.103524_bib174","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1590\/1980-57642018dn12-040003","article-title":"Focused ultrasound and Alzheimer\u2019s disease A systematic review","volume":"12","author":"Souza","year":"2018","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.tice.2026.103524_bib175","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2023114760","article-title":"RNA-based medicine: from molecular mechanisms to therapy","volume":"42","author":"Sparmann","year":"2023","journal-title":"EMBO J."},{"key":"10.1016\/j.tice.2026.103524_bib176","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3390\/pharmaceutics14102252","article-title":"Exosomes as CNS drug delivery tools and their applications","volume":"14","author":"Sun","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1303111","article-title":"Alzheimer\u2019s disease: the role of extrinsic factors in its development, an investigation of the environmental enigma","volume":"14","author":"Suresh","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tice.2026.103524_bib178","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/pharmaceutics16070849","article-title":"An overview on the physiopathology of the blood\u2013brain barrier and the lipid-based nanocarriers for central nervous system delivery","volume":"16","author":"Susa","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib179","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/pharmaceutics12121236","article-title":"Tight junction modulating bioprobes for drug delivery system to the brain: a review","volume":"12","author":"Tachibana","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib180","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41598-025-30643-9","article-title":"Evaluating the effect of minimal TIMP variants on protecting and transport across the rat brain microvascular cells (RBMEC)","volume":"16","author":"Taheri","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2026.103524_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27052370","article-title":"From polyphenols to prodrugs: bridging the blood\u2013brain barrier with nanomedicine and neurotherapeutics","volume":"27","author":"Tanaka","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib182","doi-asserted-by":"crossref","DOI":"10.1136\/svn-2023-002956","article-title":"TIMP1 protects against blood-brain barrier disruption after subarachnoid haemorrhage by inhibiting ubiquitination of astrocytic \u03b21-integrin","volume":"9","author":"Tang","year":"2024","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.tice.2026.103524_bib183","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.apsb.2020.02.015","article-title":"TIMP1 preserves the blood\u2013brain barrier through interacting with CD63\/integrin \u03b21 complex and regulating downstream FAK\/RhoA signaling","volume":"10","author":"Tang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tice.2026.103524_bib184","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/pharmaceutics14050987","article-title":"Current strategies to enhance delivery of drugs across the blood\u2013brain barrier","volume":"14","author":"Teleanu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.106939","article-title":"Blood-brain barrier targeted delivery of lacosamide-conjugated gold nanoparticles: improving outcomes in absence seizures","volume":"184","author":"Temizy\u00fcrek","year":"2022","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.tice.2026.103524_bib186","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1177\/1352458521993066","article-title":"Serum neurofilament light in MS: The first true blood-based biomarker?","volume":"28","author":"Thebault","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.tice.2026.103524_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106505","article-title":"Targeting dysregulated lipid metabolism for the treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease: current advancements and future prospects","volume":"196","author":"Tong","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tice.2026.103524_bib188","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.7150\/thno.69682","article-title":"Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy","volume":"12","author":"Upton","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.tice.2026.103524_bib189","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12951-025-03412-z","article-title":"Lipid-based nano-carriers for the delivery of anti-obesity natural compounds: advances in targeted delivery and precision therapeutics","volume":"23","author":"Uti","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.tice.2026.103524_bib190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s11671-025-04248-0","article-title":"Antioxidants in cancer therapy mitigating lipid peroxidation without compromising treatment through nanotechnology","volume":"20","author":"Uti","year":"2025","journal-title":"Discov. Nano"},{"key":"10.1016\/j.tice.2026.103524_bib191","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71519","article-title":"Theranostic Nanoparticles in Prostate Cancer: disrupting hypoxia-induced glycolysis by targeting hypoxia-inducible Factor-1 Alpha and Downstream Metabolites","volume":"15","author":"Uti","year":"2026","journal-title":"Cancer Med"},{"key":"10.1016\/j.tice.2026.103524_bib192","first-page":"S47","article-title":"The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug-resistant epilepsy","volume":"7","author":"V\u00e1zquez","year":"2021","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.tice.2026.103524_bib193","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3390\/cells13090740","article-title":"Emerging role of ABC transporters in glia cells in health and diseases of the central nervous system","volume":"13","author":"Villa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.tice.2026.103524_bib194","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.38124\/ijisrt\/IJISRT24SEP629","article-title":"Anatomical and Pathological Review of Alzheimer\u2019s, Huntington\u2019s, and Pick\u2019s Disease: a public study on the awareness of neurological disorders","author":"Vipin Katoch","year":"2024","journal-title":"Int. J. Innov. Sci. Res. Tech."},{"key":"10.1016\/j.tice.2026.103524_bib195","doi-asserted-by":"crossref","unstructured":"Wadhwa, K., CHAUHAN, P., KUMAR, S., PAHWA, R., VERMA, R., GOYAL, R., SINGH, G., SHARMA, A., RAO, N., KAUSHIK, D.: Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier. Oncol Res. 32, 877\u2013897. https:\/\/doi.org\/10.32604\/or.2024.047278.","DOI":"10.32604\/or.2024.047278"},{"key":"10.1016\/j.tice.2026.103524_bib196","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tice.2026.103524_bib197","article-title":"Progress in AAV-mediated in vivo gene therapy and its applications in central nervous system diseases","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib198","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","article-title":"Blood\u2013brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system","volume":"24","author":"Wang","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.tice.2026.103524_bib199","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1716041","article-title":"Immune-mediated blood-brain barrier disruption after ischemic stroke: mechanisms and therapeutic targets","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103524_bib200","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s11095-024-03738-7","article-title":"Distribution clearance: significance and underlying mechanisms","volume":"41","author":"Weiss","year":"2024","journal-title":"Pharm. Res"},{"key":"10.1016\/j.tice.2026.103524_bib201","series-title":"Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy","first-page":"31","article-title":"Efflux transporters in anti-cancer drug resistance: Molecular and functional identification and characterization of multidrug resistance proteins (MRPs\/ABCCs)","author":"Whitlock","year":"2020"},{"key":"10.1016\/j.tice.2026.103524_bib202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: Structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.tice.2026.103524_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma Multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tice.2026.103524_bib204","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/pharmaceutics17081041","article-title":"Overcoming the blood\u2013brain barrier: advanced strategies in targeted drug delivery for neurodegenerative diseases","volume":"17","author":"Yang","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tice.2026.103524_bib205","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70422","article-title":"Blood\u2013Brain Barrier (BBB) Dysfunction in CNS diseases: paying attention to pericytes","volume":"31","author":"Yu","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.tice.2026.103524_bib206","first-page":"213","article-title":"Blood-Brain Barrier (BBB)-crossing strategies for improved treatment of CNS disorders","volume":"284","author":"Zhang","year":"2023"},{"key":"10.1016\/j.tice.2026.103524_bib207","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2025.1644633","article-title":"Strategies for delivering drugs across the blood-brain barrier for the treatment of neurodegenerative diseases","volume":"5","author":"Zhang","year":"2025","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.tice.2026.103524_bib208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.09.017","article-title":"The barrier and interface mechanisms of the brain barrier, and brain drug delivery","volume":"190","author":"Zhang","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.tice.2026.103524_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.147937","article-title":"Factors influencing the blood-brain barrier permeability","volume":"1788","author":"Zhao","year":"2022","journal-title":"Brain Res."},{"key":"10.1016\/j.tice.2026.103524_bib210","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3390\/ijms26115131","article-title":"Therapeutic peptides: recent advances in discovery, synthesis, and clinical translation","volume":"26","author":"Zheng","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103524_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116457","article-title":"Research progress of prodrugs for the treatment of cerebral ischemia","volume":"272","author":"Zheng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tice.2026.103524_bib212","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-024-04795-z","article-title":"Focused ultrasound-mediated enhancement of blood\u2013brain barrier permeability for brain tumor treatment: a systematic review of clinical trials","volume":"170","author":"Zhu","year":"2024","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.tice.2026.103524_bib213","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.707441","article-title":"Parkinson\u2019s disease: a nanotheranostic approach targeting alpha-synuclein aggregation","volume":"9","author":"Zoey","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tice.2026.103524_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00997","article-title":"Application of pharmacokinetic-pharmacodynamic modeling in drug delivery: development and challenges","volume":"11","author":"Zou","year":"2020","journal-title":"Front. Pharm."},{"key":"10.1016\/j.tice.2026.103524_bib215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13024-024-00742-8","article-title":"The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells","volume":"19","author":"Zveik","year":"2024","journal-title":"Mol. Neurodegener."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004081662600217X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004081662600217X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:07:19Z","timestamp":1778728039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004081662600217X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":215,"alternative-id":["S004081662600217X"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103524","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-brain barrier modulation for targeted central nervous system drug delivery in neurodegenerative and demyelinating disorders","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103524"}}